Muscarinic Receptors

Introduction

Concept: A family of 7-transmembrane G-protein-coupled receptors (GPCRs) activated by acetylcholine (ACh) and muscarine. They mediate slow, sustained metabotropic responses across parasympathetic neuro-effector junctions, sympathetic sweat glands, and central neural circuits.
The Analogy:
- Tech/CS: Asynchronous Microservice API Endpoints.
- Explanation: While nicotinic receptors are direct hardware gates with zero latency, Muscarinic receptors function like asynchronous cloud service endpoints. When a ligand (Acetylcholine) hits the API port, it doesn't open a direct physical door. Instead, it triggers an internal messaging queue (G-protein cascade) that spins up secondary worker routines ( $c A M P$ reduction, $I P_{3} / D A G$ signaling, or $K^{+}$ channel tuning). This produces a smooth, prolonged, and highly regulated change in internal hardware operating parameters rather than a single sudden electrical burst.
Key Details:
- Receptor Family: Five distinct molecular subtypes ( $M_{1}$ through $M_{5}$ ).
- Signaling Split: Odd-numbered receptors ( $M_{1}, M_{3}, M_{5}$ ) are excitatory ( $G_{q}$ -coupled), while even-numbered receptors ( $M_{2}, M_{4}$ ) are inhibitory ( $G_{i}$ -coupled).

Muscarinic receptor subtypes are distributed strategically across cardiac, smooth muscle, exocrine, and central nervous tissues:

Subtype	Primary G-Protein	Intracellular Pathway	Primary Tissue Locations	Functional Physiological Response
$M_{1}$	$G_{q}$	$↑ PLC \to↑ {IP}_{3}, DAG \to↑ {Ca}^{2 +}$	CNS, autonomic ganglia, gastric parietal cells	CNS excitation, memory processing, gastric acid secretion
$M_{2}$	$G_{i}$	$↓ Adenylyl Cyclase \to↓ cAMP, ↑ K^{+} conductance$	Heart (SA node, AV node, myocardium)	Bradycardia, decreased atrial contractility, slowed AV conduction
$M_{3}$	$G_{q}$	$↑ PLC \to↑ {IP}_{3}, DAG \to↑ {Ca}^{2 +}$	Exocrine glands (salivary, lacrimal), smooth muscle, endothelium	Profuse watery salivation, bronchoconstriction, gut motility, vasodilation (via NO)
$M_{4}$	$G_{i}$	$↓ Adenylyl Cyclase \to↓ cAMP$	CNS, presynaptic nerve terminals	Autoreceptor inhibition of transmitter release, locomotion control
$M_{5}$	$G_{q}$	$↑ PLC \to↑ {IP}_{3}, DAG \to↑ {Ca}^{2 +}$	CNS (substantia nigra), cerebral blood vessels	Dopamine release modulation, cerebral vasodilation

$M_{3}$ Activation: Parasympathetic postganglionic signaling activates $M_{3}$ receptors on acinar cells of the submandibular, sublingual, and parotid glands, opening intracellular $C a^{2 +}$ channels to drive profuse, watery serous salivation containing high bicarbonate levels to buffer oral acids.

Surgical Field Management: Pre-operative administration of competitive antimuscarinics (Atropine or Glycopyrrolate) blocks $M_{3}$ receptors, halting fluid output to maintain a completely dry operating field during delicate adhesive bonding or extensive oral surgery.

Muscarinic Agonists: In patients suffering from severe dry mouth (Xerostomia) due to Sjogren's syndrome or head/neck radiation therapy, direct muscarinic agonists such as Pilocarpine or Cevimeline are prescribed to stimulate residual $M_{3}$ acinar receptors and restore protective oral fluid barriers.

Nicotinic Receptors (Ionotropic cholinergic counterparts)
Atropine (Prototype non-selective muscarinic antagonist)
Parasympathetic Nervous System (PANS) (The primary motor network deploying muscarinic transmission)
Xerostomia (Pathological breakdown of $M_{3}$ -mediated salivary flow)